KINETICS OF INTERLEUKIN-4 INDUCTION AND INTERFERON-GAMMA INHIBITION OF IGE SECRETION BY EPSTEIN-BARR VIRUS-INFECTED HUMAN PERIPHERAL-BLOOD B-CELLS

被引:11
|
作者
THYPHRONITIS, G
BANCHEREAU, J
HEUSSER, C
TSOKOS, GC
LEVINE, AD
FINKELMAN, FD
机构
[1] CIBA GEIGY AG,DIV PHARMACEUT RES,CH-4002 BASEL,SWITZERLAND
[2] SCHERING PLOUGH CORP,CTR RECH,DARDILLY,FRANCE
[3] MONSANTO CO,DEPT BIOL SCI,ST LOUIS,MO 63198
关键词
D O I
10.1016/0008-8749(91)90114-Q
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Interleukin-4 (IL-4) acts directly on purified human peripheral blood B cells cultured in the presence of Epstein-Barr virus (EBV) to induce IgE secretion and to enhance the secretion of IgG and IgM. Interferon-γ (IFN-γ) inhibits IgE secretion in this system, without affecting the secretion of the other Ig isotypes. To identify the time period during which EBV-infected B cells can be induced by IL-4 to secrete IgE, we have studied the effects of delayed addition of IL-4, or the termination of IL-4 stimulation by wash out or by neutralization with anti-IL-4 antibodies, on the induction of an IgE response. To induce a maximal IgE response, IL-4 had to be added to cultures of B cells plus EBV no later than 2 days after the initiation of culture, and had to remain present through the tenth day of culture. These two time points correspond to the initiation of detectable DNA synthesis (Days 3 to 4) and the earliest detectable Ig secretion (Days 10 to 12) by EBV-stimulated B cells. No IgE response was induced if the period during which EBV-stimulated B cells were cultured with IL-4 was less than 4 days, or if IL-4 were added later than the tenth day of culture, regardless of how long the culture was continued beyond that time. In contrast, IL-4 considerably enhanced IgG and IgM secretion and B cell CD23 expression, even if it was added after the tenth day of culture. IFN-γ strongly inhibited the IgE response of B cells cultured with IL-4 plus EBV if added within 6 days of the initiation of culture, but had little effect on the generation of IgM or IgG responses made by these cells, regardless of the time of addition. Neither IL-4 nor IFN-γ affected ongoing IgE secretion by an established, IgE-secreting, EBV-transformed cell line. These observations suggest that: (i) IL-4 first becomes able to induce EBV-activated B cells to secrete IgE as these cells begin to synthesize DNA, must stimulate B cells for at least 4 days to induce IgE secretion, and loses its ability to induce IgE secretion as these cells differentiate into Ig-secreting cells; (ii) the ability of IFN-γ to suppress an IgE response is limited to this same time period; and (iii) IL-4 enhancement of CD23 expression and IgM and IgG secretion are independent of IL-4 induction of an IgE response. © 1991.
引用
收藏
页码:408 / 419
页数:12
相关论文
共 50 条
  • [1] IGE SECRETION BY EPSTEIN-BARR VIRUS-INFECTED PURIFIED HUMAN LYMPHOCYTES-B IS STIMULATED BY INTERLEUKIN-4 AND SUPPRESSED BY INTERFERON-GAMMA
    THYPHRONITIS, G
    TSOKOS, GC
    JUNE, CH
    LEVINE, AD
    FINKELMAN, FD
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (14) : 5580 - 5584
  • [2] PRODUCTION OF IGE BY PURIFIED, EPSTEIN-BARR VIRUS (EBV)- INFECTED, HUMAN B-CELLS IS INDUCED BY INTERLEUKIN-4 (IL-4) AND SUPPRESSED BY INTERFERON GAMMA (IFN-GAMMA)
    THYPHRONITIS, G
    TSOKOS, GC
    JUNE, C
    LEVINE, A
    FINKELMAN, FD
    CLINICAL RESEARCH, 1989, 37 (02): : A515 - A515
  • [3] INTERLEUKIN-4 INDUCES BOTH IGG4 AND IGE SECRETION BY PERIPHERAL-BLOOD B-CELLS
    NUSSLEIN, HG
    SPIEGELBERG, HL
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 1990, 4 (06) : 414 - 419
  • [4] CHARACTERISTICS OF VIRAL PROTEIN EXPRESSION BY EPSTEIN-BARR VIRUS-INFECTED B-CELLS IN PERIPHERAL-BLOOD OF PATIENTS WITH INFECTIOUS-MONONUCLEOSIS
    WAGNER, HJ
    HORNEF, M
    MIDDELDORP, J
    KIRCHNER, H
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1995, 2 (06) : 696 - 699
  • [5] EFFECTS OF INTERLEUKIN-4 AND INTERFERON-GAMMA ON THE SECRETION OF IGG4 FROM HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS
    SUTHERLAND, M
    BLASER, K
    PENE, J
    ALLERGY, 1993, 48 (07) : 504 - 510
  • [6] ELEVATED EPSTEIN-BARR VIRUS-INFECTED B-CELLS IN THE BLOOD OF PATIENTS WITH RHEUMATOID-ARTHRITIS
    TOSATO, G
    STEINBERG, AD
    YARCHOAN, R
    PIKE, SE
    DESEAU, V
    BLAESE, RM
    CLINICAL RESEARCH, 1983, 31 (02): : A522 - A522
  • [7] INHIBITION OF EPSTEIN-BARR VIRUS TRANSFORMATION OF B-CELLS BY 3'-AZIDO-3'-DEOXYTHYMIDINE AND INTERFERON-ALPHA AND INTERFERON-GAMMA
    LIN, JC
    ZHANG, ZX
    SIM, I
    PAGANO, JS
    ANTIVIRAL RESEARCH, 1988, 9 (1-2) : 108 - 108
  • [8] THE EPSTEIN-BARR VIRUS-INDUCED PRODUCTION OF IGE BY HUMAN B-CELLS
    MARTINEZMAZA, O
    GUILBERT, B
    DAVID, B
    AVRAMEAS, S
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1986, 39 (03): : 405 - 413
  • [9] CHARACTERIZATION OF EFFECTOR LYMPHOCYTES AGAINST AUTOLOGOUS EPSTEIN-BARR VIRUS-INFECTED B-CELLS
    TSOUKAS, CD
    FOX, RI
    SLOVIN, SF
    FONG, S
    CARSON, D
    VAUGHAN, JH
    CLINICAL RESEARCH, 1981, 29 (02): : A378 - A378
  • [10] MEMBRANE ANTIGEN ON EPSTEIN-BARR VIRUS-INFECTED HUMAN B-CELLS RECOGNIZED BY A MONOCLONAL-ANTIBODY
    SLOVIN, SF
    FRISMAN, DM
    TSOUKAS, CD
    ROYSTON, I
    BAIRD, SM
    WORMSLEY, SB
    CARSON, DA
    VAUGHAN, JH
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (08): : 2649 - 2653